Align alanine-glyoxylate transaminase (EC 2.6.1.44); serine-glyoxylate transaminase (EC 2.6.1.45) (characterized)
to candidate GFF2363 PGA1_c23940 putative serine-glyoxylate aminotransferase
Query= BRENDA::Q56YA5 (401 letters) >lcl|FitnessBrowser__Phaeo:GFF2363 PGA1_c23940 putative serine-glyoxylate aminotransferase Length = 421 Score = 235 bits (600), Expect = 2e-66 Identities = 143/400 (35%), Positives = 219/400 (54%), Gaps = 20/400 (5%) Query: 2 DYMYGPGRHHLFVPGPVNIPEPVIRAMNRNNEDYRSPAIPALTKTLLEDVKKIFKTTSGT 61 D GR +L +PGP IP+ V++AM+R + + + + +T TL+ D++++ +T Sbjct: 4 DVSLAAGRGYLAIPGPSVIPDAVLQAMHRPSPNIYAGELVEMTATLIPDLRRVARTEHNV 63 Query: 62 PFLFPTTGTGAWESALTNTLSPGDRIVSFLIGQFSLLWIDQQKRLNFNVDVVESDWGQGA 121 ++ + G GAWE+AL NTL PGD ++ G+F++ W + + L V++++ G Sbjct: 64 A-IYISNGHGAWEAALQNTLQPGDTVLVASSGRFAIGWSEMAEALGIKVELLDFGTGAPW 122 Query: 122 NLQVLASKLSQDENHTIKAICIVHNETATGVTNDISAVRTLLDHYKHPALLLVDGVSSIC 181 ++ +AS L+ D H IKA+ VH +T++ + ND++A+R LD HPALL+ D ++S+ Sbjct: 123 DMDRIASHLAADTAHRIKAVLAVHVDTSSSIRNDVAAMRAALDACDHPALLMADCIASLG 182 Query: 182 ALDFRMDEWGVDVALTGSQKALSLPTGLGIVCASPKALEATKTSKSLKVFFDWNDYLKFY 241 F MD WGVDV + QK L +P G+G V SPKA EA + ++DW Sbjct: 183 CDRFEMDAWGVDVMVAACQKGLMVPAGMGFVFFSPKAAEARARLPRVSRYWDWEPRANPE 242 Query: 242 KLGTYWPYTPSIQLLYGLRAALDLIFEEGLENIIARHARLGKATRLAVEAWG----LKNC 297 + Y+ T LYGLRAALDLI EG+E + ARH RL +A A + WG L+ Sbjct: 243 EFYQYFGGTAPTHHLYGLRAALDLIHGEGMEAVWARHHRLAQAIWAACDRWGDGGPLRMN 302 Query: 298 TQKEEWISNTVTAVMVPPHIDGSEIVR-RAW--QRYNLSLGLGLNKVAGK------VFRI 348 Q SN VT++ H+ G E R R W Q L+LG+GL R+ Sbjct: 303 VQDVALRSNAVTSL----HLGGDEATRLRTWVEQTLGLTLGIGLGMAPPNSPEWHGFLRL 358 Query: 349 GHLGNVNELQLLGCLAGVEMILKDVGYPVVMGSGVAAAST 388 GH+G+V+ ++G L GV+ LK + P GSG A++ Sbjct: 359 GHMGHVSGQMIMGLLGGVDAGLKALEIP--HGSGALEAAS 396 Lambda K H 0.320 0.137 0.419 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 423 Number of extensions: 21 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 401 Length of database: 421 Length adjustment: 31 Effective length of query: 370 Effective length of database: 390 Effective search space: 144300 Effective search space used: 144300 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Aug 03 2021. The underlying query database was built on Aug 03 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code, or see changes to Amino acid biosynthesis since the publication.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory